Kahn JA, Belzer M, Chi Z, Lee J, Gaur AH, Mayer K, Martinez J, Futterman D, Stier EA, Paul ME, Chiao EY, Reirden D, Goldstone SE, Martinez APO, Cachay ER, Barroson LF, Da Costa M, Wilson CM, Palefsky JM, for the AIDS Malignancy Consortium and Adolescent Medicine Trials Network for HIV/AIDS Interventions. Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men. Papillomavirus Research. 2019.
Covert C, Ding L, Brown DR, Bernstein DI, Franco EL, Kahn JA. Evidence for cross-protection but not type-replacement over the 11 years after Human Papillomavirus vaccine introduction. Human Vaccines & Immunotherapeutics. 2019.
Spinner C, Ding L, Bernstein DI, Brown DA, Franco EL, Kahn JA. Human papillomavirus vaccine effectiveness and herd protection in young women: 2006-2017. Pediatrics. 2019;143:e20181902.
Chandler E, Ding L, Gorbach P, Franco EL, Brown DA, Widdice LE, Bernstein DI, Kahn JA. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus among 13-26 Year-Old Young Men after HPV Vaccine Introduction. Journal of Adolescent Health. 2018;63:43-49.
Hackworth J, Steel S, DePalma M, Cooksey E, Kahn JA. Faculty Members’ Self-Awareness, Leadership Confidence, and Leadership Skills Improve after an Evidence-Based Leadership Training Program. Journal of Pediatrics. 2018;199:4-6.e2.
Rosen B, Shepard A, Kahn JA. U.S. Healthcare Clinicians' Knowledge, Attitudes and Practices regarding HPV Vaccination: A Qualitative Systematic Review. Academic Pediatrics. 2018;18:S53-S65.
Mullins TLK, Rosenthal SL, Zimet GD, Ding L, Morrow C, Huang B, Kahn JA. HPV vaccine-related risk perceptions do not predict sexual initiation among young women over 30 months following vaccination. Journal of Adolescent Health. 2017.
Kahn JA, Xu J, Kapogiannis BG, Sleasman JW. Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay. JAIDS. 2017;75:241-245.
Kahn JA, Lee J, Belzer M, Palefsky JM. HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination. AIDS and Behavior. 2017.
Kahn JA, Widdice LE, Ding L, Huang B, Brown DR, Franco EL, Bernstein DI. Substantial decline in vaccine-type human papillomavirus (HPV) among vaccinated young women during the first 8 years after HPV vaccine introduction in a community. Clin Infect Dis. 2016;63(10):1281-1287.